Insider Cluster (2 insiders) ·Filed Aug 7, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizondays Processed1mo ago
Insider cluster: 2 insiders, $228K total
Actionable Insight • Neutral

This insider cluster is routine post-earnings option exercise-and-sell activity with no material signal. The dollar amount is negligible relative to market cap. Monitor the next 10-Q for any revenue trend deterioration following the Q2 top-line miss, but this insider activity alone does not warrant any trading action.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d ⚠ clustered
UTHR ▼ -9.51% at T+20d
NEUTRAL call ✗ call lost -9.51% · α vs SPY -9.11% · entry $538.84 → $487.61
Next anchor: T+60d in 28d
Latest observation: T+37 +4.27% FF3 residual α
Entry anchored
Aug 6, 04:37 PM ET
via 1-min bar
T+1d
-1.70%
call -1.70% · α -1.67%
$529.66
settled 8w ago
T+5d
-7.26%
call -7.26% · α -7.66%
$499.73
settled 7w ago
T+20d
-9.51%
call -9.51% · α -9.11%
$487.61
settled 29d ago
T+60d
—
call — · α —
—
in 28d

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt and EVP/GC Paul Mahon sold a combined ~$7.5M in open-market shares on August 6, 2026, the day after UTHR reported mixed Q2 results (revenue miss, EPS beat). Both insiders also exercised stock options (non-cash events) on the same day, indicating this is routine post-earnings option exercise-and-sell activity following the blackout window opening. At 0.033% of UTHR's $22.6B market cap, the dollar value is trivial and carries no material signal — the cluster is consistent with standard post-earnings insider selling patterns, not informed negative conviction.

Key Financial Metrics

Direction
selling
Total Value
$7.5M
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold ~$3.2M in open-market shares on Aug 6, 2026
  • EVP/GC Paul Mahon sold ~$4.3M in open-market shares on Aug 6, 2026
  • Both insiders exercised stock options (non-cash) on the same day — Rothblatt 9,500 shares at $0, Mahon 8,300 shares at $146.03
  • Total open-market sales of ~$7.5M represent only 0.033% of UTHR's $22.6B market cap
  • Cluster occurred one day after UTHR's Q2 2026 earnings release (Aug 5), consistent with post-blackout-window opening
  • Q2 revenue of $783.3M missed $804.6M consensus (-2% YoY); EPS of $7.27 beat $6.86 estimate

Financial Impact

Total insider open-market sales of ~$7.5M (0.033% of market cap) — economically trivial

insider_sellingoption_exercises

Risk Factors

  • Revenue decline of 2% YoY in Q2 may signal competitive headwinds in inhaled prostacyclin market
  • Tyvaso Nebulized sales dropped 18% YoY, partially offset by Tyvaso DPI growth
  • No insider buying to offset the selling — consistent with lack of bullish conviction from management

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1786165565043
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Closed — Opens in 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 8, 2026